STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2017-2022

  Sato, Norihiro ^a   Rosty, Christophe ^a   Jansen, Marnix ^a   Fukushima, Noriyoshi ^a   Ueki, Takashi ^a   Yeo, Charles J ^a   Cameron, John L ^a   Iacobuzio Donahue, Christine A ^a   Hruban, Ralph H ^a   Goggins, Michael ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MICROSATELLITE DNA; PROTEIN KINASE LKB1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 19P; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; GENE INACTIVATION; GENE LOCUS; GENE MUTATION; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PATHOGENESIS; PEUTZ JEGHERS SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0035184065     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63053-2     Document Type: Article

References (46)

1. Intraductal papillary tumors and mucinous cystic tumors of the pancreas: Clinicopathologic study of 38 cases
2. Intraductal papillary mucinous neoplasms of the pancreas associated with socalled mucinous ductal ectasia: Histochemical and immunohistochemical analysis of 29 cases
3. Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic
4. Clinicopathologic view of intraductal papillary-mucinous tumor of the pancreas
5. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature
6. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity
7. Intraductal neoplasms of the pancreas
8. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas
9. The prognosis of intraductal papillary mucinous tumors of the pancreas
10. Progress in cancer genetics: Lessons from pancreatic cancer
11. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas
12. Ras gene mutations in intraductal papillary neoplasms of the pancreas: Analysis in five cases
13. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas
14. Genetic progression and heterogeneity in intraductal papillary-mucinous neoplasms of the pancreas
15. Pancreatic tumours: Molecular pathways implicated in ductal cancer are involved in ampullary but not in exocrine nonductal or endocrine tumorigenesis
16. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53, and c-erbB-2 abnormalities in 26 patients
17. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: Comparison with conventional ductal adenocarcinomas
18. Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
19. Exclusion of SMAD4 mutation as an early genetic change in human pancreatic ductal tumorigenesis
20. Generalized intestinal polyposis and melanin spots of the oral mucosa, lip, and digitis: A syndrome of diagnostic significance
21. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis
22. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome
23. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase
24. Growth suppression by Lkb1 is mediated by a G1 cell cycle arrest
25. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death
26. Cancer in Peutz-Jeghers syndrome
27. Increased risk for cancer in patients with the Peutz-Jeghers syndrome
28. Increased risk of cancer in the Peutz-Jeghers syndrome
29. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers
30. Tumors of the pancreas
31. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections
32. BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: Evidence and implications
33. Somatic mutations in the STK11/LKB1 gene are uncommon in rare gynecological tumor types associated with Peutz-Jegher's syndrome
34. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
35. Prevention of pancreatic cancer and strategies for management of familial pancreatic cancer
36. Tumor-suppressive pathways in pancreatic carcinoma
37. Abrogation of the Rb/p16 tumorsuppressive pathway in virtually all pancreatic carcinomas
38. STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer
39. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors
40. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer
41. An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers
42. Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence
43. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours
44. Allelotype of pancreatic adenocarcinoma
45. Conversion of diploidy to haploidy
46. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome